Anal carcinoma in inflammatory bowel disease

We followed 9602 patients with Crohn's disease or ulcerative colitis for anal squamous cell carcinoma for up to 18 years. No significant increase was observed: two cases occurred vs 1.3 expected during 99 229 person-years of observation, (standardized incidence ratio = 1.6; 95 confidence interv...

Descripción completa

Detalles Bibliográficos
Autores principales: Frisch, M, Johansen, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374535/
https://www.ncbi.nlm.nih.gov/pubmed/10883673
http://dx.doi.org/10.1054/bjoc.2000.1153
_version_ 1782154476594921472
author Frisch, M
Johansen, C
author_facet Frisch, M
Johansen, C
author_sort Frisch, M
collection PubMed
description We followed 9602 patients with Crohn's disease or ulcerative colitis for anal squamous cell carcinoma for up to 18 years. No significant increase was observed: two cases occurred vs 1.3 expected during 99 229 person-years of observation, (standardized incidence ratio = 1.6; 95 confidence interval: 0.2–5.7). Anal squamous cell carcinoma is rare even in inflammatory bowel disease. © 2000 Cancer Research Campaign
format Text
id pubmed-2374535
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23745352009-09-10 Anal carcinoma in inflammatory bowel disease Frisch, M Johansen, C Br J Cancer Short Communication We followed 9602 patients with Crohn's disease or ulcerative colitis for anal squamous cell carcinoma for up to 18 years. No significant increase was observed: two cases occurred vs 1.3 expected during 99 229 person-years of observation, (standardized incidence ratio = 1.6; 95 confidence interval: 0.2–5.7). Anal squamous cell carcinoma is rare even in inflammatory bowel disease. © 2000 Cancer Research Campaign Nature Publishing Group 2000-07 2000-06-02 /pmc/articles/PMC2374535/ /pubmed/10883673 http://dx.doi.org/10.1054/bjoc.2000.1153 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Short Communication
Frisch, M
Johansen, C
Anal carcinoma in inflammatory bowel disease
title Anal carcinoma in inflammatory bowel disease
title_full Anal carcinoma in inflammatory bowel disease
title_fullStr Anal carcinoma in inflammatory bowel disease
title_full_unstemmed Anal carcinoma in inflammatory bowel disease
title_short Anal carcinoma in inflammatory bowel disease
title_sort anal carcinoma in inflammatory bowel disease
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374535/
https://www.ncbi.nlm.nih.gov/pubmed/10883673
http://dx.doi.org/10.1054/bjoc.2000.1153
work_keys_str_mv AT frischm analcarcinomaininflammatoryboweldisease
AT johansenc analcarcinomaininflammatoryboweldisease

Ejemplares similares